| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$92 |
BB1 Expands Pivotal FDA Trial Network to Nine Elite Sites
|
12 Feb 2026 9:31AM |
$1.030 |
$0.605 |
fallen by
41.26%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$8 |
Mobilisation Underway with Drilling to Commence Imminently
|
12 Feb 2026 9:31AM |
$0.071 |
$0.038 |
fallen by
46.48%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Mobilisation underway with diamond drilling to commence imminently at the Commonwealth Gold–Silver Project.
- Kuniko to initiate Phase-1 drilling targeting extensions of high-grade gold-silver systems.
- Drilling to test approximately 1,200 metres across the Commonwealth Main, Silica Hill, and Commonwealth South.
- The project is situated within a district-scale mineralised trend identified by a MobileMT survey.
- Titeline Drilling contracted for the execution of the drilling program.
- Program aims to expand known mineralisation and support future resource growth.
- Kuniko's strategy includes leveraging historical data and advanced geophysical surveys.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$83 |
Quantum program advances with ecosystem-led execution
|
12 Feb 2026 9:30AM |
$0.370 |
$0.325 |
fallen by
12.16%
|
|
| Sportshero Limited (SHO) ORDINARY FULLY PAID |
Communication Services |
$64 |
Trading Halt
|
12 Feb 2026 9:28AM |
$0.088 |
$0.072 |
fallen by
18.18%
|
|
SHO - Price-sensitive ASX Announcement
Full Release
Key Points
- SportsHero Limited requested a trading halt.
- The halt is pending an announcement related to fundraising completion.
- The trading halt is expected to be lifted by 16 February 2026.
- The company is not aware of any reasons against the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$52 |
SB2 Investment Report & NTA Update
|
12 Feb 2026 9:28AM |
$0.750 |
$0.620 |
fallen by
17.33%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$11 |
Proposed issue of securities - DUN
|
12 Feb 2026 9:27AM |
$0.046 |
$0.047 |
risen by
2.17%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$11 |
Exploration Funded
|
12 Feb 2026 9:27AM |
$0.046 |
$0.047 |
risen by
2.17%
|
|
DUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful $2.5M share placement for Dundas Minerals Limited.
- Funds will support gold exploration in Kalgoorlie and Yamarna.
- Strong investor support with treasury exceeding $3M.
- Drilling to commence in March 2026 at Rockland Project.
- Romano Project located near Gruyere gold mine.
- No mineral resources or ore reserves estimated for Romano Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paladin Energy Ltd (PDN) ORDINARY FULLY PAID |
Energy |
$5,707 |
Appendix 4D and December 2025 Half Year Financial Results
|
12 Feb 2026 9:26AM |
$12.250 |
$12.700 |
risen by
3.67%
|
|
PDN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from uranium sales amounted to US$138.3 million.
- Gross profit for the period was US$26.0 million.
- Total finance costs were US$15.9 million.
- Net profit after tax of US$3.3 million was reported.
- Total assets stood at US$1,324.6 million as of 31 December 2025.
- Total liabilities were US$272.7 million, leading to net assets of US$1,051.9 million.
- Cash and cash equivalents at the end were US$121 million.
- Significant capital raises were completed through ASX and Canadian placements.
- Ongoing investment in mine development and exploration was noted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$100 |
Update - Notification of buy-back - CAM
|
12 Feb 2026 9:26AM |
$0.700 |
$0.705 |
risen by
0.71%
|
|
| Humm Group Limited (HUM) ORDINARY FULLY PAID |
Financials |
$335 |
Chair Appointment & Board Expansion
|
12 Feb 2026 9:25AM |
$0.735 |
$0.670 |
fallen by
8.84%
|
|
| Manuka Resources Ltd (MKR) ORDINARY FULLY PAID |
Materials |
$166 |
Response to ASX aware letter
|
12 Feb 2026 9:25AM |
$0.140 |
$0.110 |
fallen by
21.43%
|
|
MKR - Price-sensitive ASX Announcement
Full Release
Key Points
- Manuka Resources addressed the ASX Aware Letter regarding its disclosure obligations.
- Draft decision from the EPA regarding the Taranaki VTM Project was deemed material.
- The decision was announced to the market once it was no longer uncertain.
- Share price decline on 5 February 2026 was linked to market conditions, not the draft decision.
- Cleansing Notice issued by Manuka on 4 February 2026 was validly issued.
- Manuka confirmed compliance with ASX Listing Rules and internal disclosure policies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$217 |
Cleansing Notice under s708A(5)(e) of the Corporations Act
|
12 Feb 2026 9:24AM |
$2.220 |
$0.795 |
fallen by
64.19%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$8 |
Exploration Update
|
12 Feb 2026 9:23AM |
$0.150 |
$0.070 |
fallen by
53.33%
|
|
T88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Taiton Resources Limited conducted a shallow regolith RC drilling program to test surface geochemical anomalism.
- Pathfinder element anomalism and mineral alteration indicate a favorable geological setting for potential gold mineralisation.
- Future exploration plans include staged surface geochemical sampling focusing on areas with historical elevated gold in calcrete results.
- The Challenger West project targets gold mineralisation similar to the Challenger deposit.
- Taiton has appointed a drilling contractor for the Yogi prospect to test a 6 mGal gravity anomaly.
- The Yogi prospect is located in the Gawler Craton and shows potential for Iron-Oxide-Copper-Gold (IOCG) style or Carbonatite Hosted REE mineralisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,213 |
2026 Half-Year Results Presentation and Speaking Notes
|
12 Feb 2026 9:23AM |
$55.380 |
$57.380 |
risen by
3.61%
|
|
| GBM Resources Limited (GBM) ORDINARY FULLY PAID |
Materials |
$137 |
50,000m Stage 2 Drilling Program Commences at Twin Hills
|
12 Feb 2026 9:23AM |
$0.035 |
$0.028 |
fallen by
20%
|
|
| CZR Resources Ltd (CZR) ORDINARY FULLY PAID |
Materials |
$60 |
Croydon Gold Project - Strong Initial Gold Assay Results
|
12 Feb 2026 9:23AM |
$0.380 |
$0.250 |
fallen by
34.21%
|
|
CZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant gold assay results announced from Croydon Gold Project's Top Camp deposit.
- First major drilling program at Croydon in five years.
- Assays confirm Top Camp as a new gold system within the Mallina Basin.
- Recent drilling intersected substantial gold mineralisation, such as 51m at 1.3g/t Au and 4m at 5.1g/t Au.
- These results build on initial mineralisation discovered in 2019.
- Updated geological model developed, enabling targeted mineralisation discovery.
- Plans to resume drilling at Top Camp and start at Bottom Camp are underway.
- Focus on high-priority prospects, including expansion of Frank’s Patch.
- Further assays are expected in the coming weeks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$252 |
Trading Halt
|
12 Feb 2026 9:23AM |
$0.415 |
$0.310 |
fallen by
25.30%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- Prospect Resources Limited (ASX: PSC) requests a trading halt.
- The trading halt is pending a significant announcement about a material capital raise.
- The halt will end by 16 February 2026 or upon the announcement release.
- PSC is not aware of reasons against the trading halt.
- Issued by ASX Compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,213 |
2026 Half-Year Results Presentation Slides
|
12 Feb 2026 9:23AM |
$55.380 |
$57.380 |
risen by
3.61%
|
|
ASX - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H26 financial results summary by CEO Helen Lofthouse.
- ASX maintained a statutory return on equity of 13.5%.
- Basic earnings per share amounted to 135.7 cents.
- Total assets were reported at $15,951.5 million.
- Total liabilities stood at $12,046.7 million.
- Presentation addressed an ASIC inquiry and transformation strategy.
- Emphasis on customer-driven growth opportunities.
- Strong focus on technological advancements to enhance market position.
- Increased trading volumes and strategic capital investments highlighted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,213 |
2026 Half-Year Results Market Release
|
12 Feb 2026 9:22AM |
$55.380 |
$57.380 |
risen by
3.61%
|
|
ASX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue grew by 11.2% to $602.8 million.
- Underlying net profit after tax increased by 3.9% to $263.6 million.
- Total operating expenses increased by 20.0%.
- Focused on technology modernization and launched new products.
- Declared a fully franked interim dividend of 101.8 cents per share.
- Dividend payout ratio was 75%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$217 |
Application for quotation of securities - LOT
|
12 Feb 2026 9:21AM |
$2.220 |
$0.795 |
fallen by
64.19%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$13,156 |
CEO Interview - 1HY26
|
12 Feb 2026 9:21AM |
$169.470 |
$125.930 |
fallen by
25.69%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- 30% growth in underlying profit after tax.
- Seven new sales totaling $280 million.
- Investment in 4D Medical showed substantial gains.
- Focus on organic growth over M&A.
- Utilizing cash reserves for business investment.
- AI seen as a tool, not a disruptor.
- Expansion in cardiology offerings.
- Strategic contract with University Hospital Heidelberg.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,213 |
Dividend/Distribution - ASX
|
12 Feb 2026 9:21AM |
$55.380 |
$57.380 |
risen by
3.61%
|
|
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,213 |
Appendix 4D and 2026 Half-Year Financial Statements
|
12 Feb 2026 9:20AM |
$55.380 |
$57.380 |
risen by
3.61%
|
|
ASX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net assets increased to $3,904.8 million by 31 December 2025.
- Operating revenue for the half-year was $602.8 million, up 11.2%.
- Statutory net profit after tax was $263.6 million.
- Earnings per share increased to 135.7 cents.
- Operating expenses, excluding significant items, totaled $247.0 million.
- Decrease in cash and financial assets by 12.1%.
- Significant changes in right-of-use assets and lease liabilities due to new lease arrangements.
- Total equity increased slightly with higher retained earnings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carnaby Resources Limited (CNB) ORDINARY FULLY PAID |
Materials |
$149 |
Shallow High Grade Results Bolster Trek 1 - 7m @ 8.9% CuEq
|
12 Feb 2026 9:20AM |
$0.470 |
$0.540 |
risen by
14.89%
|
|
CNB - Price-sensitive ASX Announcement
Full Release
Key Points
- Shallow high-grade drill results bolster development potential at Trek 1.
- Key result includes 7m at 8.9% CuEq from 35m.
- Historical underground mining at Trek 1 from 1911-1945.
- Carnaby is conducting a pre-feasibility study for open-pit mining.
- Further drilling and assessments are underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$13,156 |
Company Announcement - Interim Results
|
12 Feb 2026 9:19AM |
$169.470 |
$125.930 |
fallen by
25.69%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 28.4% to $124.8 million.
- Underlying profit before tax rose by 29.7% to $90.7 million.
- Reported net profit after tax surged by 230.9% to $171.2 million.
- Unrealised gains from 4D Medical Limited investment included.
- Cash and financial assets grew to $221.8 million.
- The company remains debt-free.
- Declared fully franked interim dividend of 32 cents per share.
- Secured seven new contracts totaling over $280 million.
- New contracts include offerings in cardiology and Visage 7 products.
- Continued focus on cloud-based implementations and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
